Mr. Willis is a Founding Partner of MED1 Ventures. Tim has more than 30 years of ophthalmology industry experience having founded or help found 8 companies. Tim is a seasoned business executive and entrepreneur and inventor having raised $195 million in funding, over 30 issued patents, and responsible for the development and launch of 55 ophthalmic products that today represent over one and half billion dollars in annual sales.

Mr. Bacich is the Chief Technology Officer and Founding Partner of MED1 Ventures. Steve has more than 20 year of medical device industry experience with over 15 years focused on women’s health. Mr. Bacich completed several venture and public funding rounds in total raising over $250 million. Steve has over 50 issued US medical device patents and has brought over 25 products to market.

Mr. Geer is a former partner with Ernst & Young. Kent has more than 30 years of experience and track record serving numerous public and private companies in a variety of industries including biotechnology, medical device, pharmaceuticals and other technology companies. During his tenure, Mr. Geer was the audit practice leader for Ernst & Young Entrepreneurial Services Group and was the market team leader for the technology industry practice.

Mr. Lee has more than 35 years in the healthcare and medical device industry in Asia. He has 10+ years experiences with top multinational medical device companies as the General Manager of Greater China and Asia. Duane in 1997 founded and built a several hundred-million-dollar Chinese business, taking the company public on the Taipei Exchange. Duane’s expertise and background in marketing and sales with medical devices covers Bio-Research, IVD, Radiation Oncology, and Ophthalmology and has successfully launched these technologies and products in Asia.

Mr. Reichardt is a Managing Partner International Business Development with over 35 years of experience in sales, marketing, and European business and general management expertise. Diethart has served in leadership positions for several global medical device and pharmaceutical companies in ophthalmology and women’s health.